Following a two-year evaluation period, Bayer MaterialScience is planning to commercialize using carbon dioxide as a raw precursor for polyurethane foam production.
Bayer said its goal will be to initially make bigger amounts with this precursor accessible to “particular central processing units” from 2015.
Additional details of investment in a building schedule or the job isn’t yet accessible, a Bayer spokesman told Urethanes Technology International.
Using CO2 replaces some of the fossil fuel raw materials, including oil, that would be used alone, Bayer said. The new procedure to supply economical advantages over a conventional generation system is also expected by the chemical giant.
Bayer said it collaborated with partners from academia and business to develop the procedure, which has been examined intensively over the last two years. A pilot plant at Bayer’s primary site in Leverkusen made smaller amounts of the precursor polyol, where the CO2 is bound within the funded research project Bayer calls Dream Creation.
“After successfully finishing the evaluation period, we’re now starting Phase 2 with the goal of commercialization,” Thomas noted. The first use of the new CO2-established foam that is flexible will be for the creation of mattresses.
Thomas included that Bayer is eager to license the carbon dioxide to desirable partners to polyol technology.